|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
|
|---|---|---|---|---|---|
| REVENUES | |||||
| Revenue | |||||
| Cost and operating expenses: | |||||
| Cost of revenue (excluding depreciation and amortization) | |||||
| Product development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Acquisition costs | |||||
| Impairment of goodwill and intangible assets | |||||
| Depreciation and amortization | |||||
| Impairment of goodwill | |||||
| Total cost and operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Interest expense, net | |||||
| Interest expense related to debt discount and conversion feature | |||||
| Gain on sale of assets | |||||
| Change in fair value of derivative and warrant liabilities | |||||
| Loss on extinguishment of debt | |||||
| Gain on equity investment | |||||
| Amortization of deferred financing costs | |||||
| Other income (expense), net | |||||
| Total other expense | |||||
| Loss before (benefit) provision for income tax | |||||
| Income tax benefit | |||||
| Net loss | |||||
| Foreign currency translation loss | |||||
| COMPREHENSIVE LOSS | |||||
| Net loss per common share and equivalents - basic and diluted | |||||
| Accretion and dividends of series C redeemable preferred stock | |||||
| Net loss attributable to common equity | |||||
| Loss per common share - basic (in dollars per share) | |||||
| Loss per common share - diluted (in dollars per share) | |||||
| Weighted average shares outstanding - basic (in shares) | |||||
| Weighted average shares outstanding - diluted (in shares) | |||||
Loading...